???? Today is Rare Disease Day – A Day for Awareness, Hope, and Action! Did you know that over 300 million people worldwide live with a rare disease? While each condition may be rare, the challenges faced by those affected—patients, families, and caregivers—are far too common: delayed diagnoses, limited treatment options, and a need for more research and awareness. On this day, we stand in solidarity with the rare disease community, advocating for better access to care, stronger support networks, and continued medical advancements. Together, we can create a world where no one feels alone in their journey. ?? Raise awareness ?? Show support ?? Advocate for change Let’s make rare visible! ?? https://lnkd.in/gk6hbAF #RareDiseaseDay #Symbio #GlobalCRO
Symbio
制药业
Port Jefferson，NY 5,201 位关注者
Dermatology Client-Focused Global Full-service CRO -Core Services In-House. PoC, device and Phases I-IV Clinical Studies
关于我们
Headquartered in Port Jefferson, NY, Symbio is a client-focused global full-service Clinical Research Organization (CRO). We manage all CRO core services in-house and have our offices in the USA and Europe. We deliver excellent service and provide experienced qualified personnel to strategically manage all aspects of your clinical trials. In November of 2023, NY-headquartered Symbio, LLC and CA-headquartered Dow Development Laboratories, LLC merged with Münster (Germany)-based Proinnovera. This merger created one of the world’s largest specialized dermatology-focused clinical research organization. In September of 2024, after a successful integration process, the group was renamed from Symbio Proinnovera to Symbio. Symbio offers expertise in Proof-of-Concept, medical device and Phase 1 – Phase 4 clinical studies and has completed over 650+ clinical studies to date, both in the USA and in Europe. Developing and maintaining excellent relationships with experienced clinical research sites are vital to the success of any study and every CRO. As a direct result of our site relationships, Symbio trials receive the special attention they deserve. We take great pride in the strong relationships we have established over the years. These relationships have provided us the ability to streamline recruitment, creating shorter enrollment timelines with a lower number of sites.
- 网站
-
https://www.symbioresearch.com
Symbio的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Port Jefferson，NY
- 类型
- 私人持股
- 创立
- 2002
- 领域
- Project Management、Data Management、Statistics、Monitoring、Medical Monitoring、Clinical Study Reports、Protocol Development、Clinical Trial Management、Dermatology、Topical Generics、Topical Formulation、Skin、Skincare、Clinical Trials和Study design
地点
Symbio员工
动态
-
Symbio转发了
?? Countdown to AAD2025: 7 Days to go! The Symbio and Dow Development Laboratories, LLC (DDL) team is excited to attend the annual American Academy of Dermatology Meeting in Orlando, Florida, next week, where we will be exhibiting. We eagerly anticipate the AAD meeting each year and are delighted to have the opportunity to engage with both current and former business associates and clients. Please visit us at booths 2774 and 2776. We look forward to the opportunity to connect with you in sunny Orlando. ?? #AAD2025 #GlobalCRO #DermatologyCRO
-
-
?? Countdown to AAD2025: 7 Days to go! The Symbio and Dow Development Laboratories, LLC (DDL) team is excited to attend the annual American Academy of Dermatology Meeting in Orlando, Florida, next week, where we will be exhibiting. We eagerly anticipate the AAD meeting each year and are delighted to have the opportunity to engage with both current and former business associates and clients. Please visit us at booths 2774 and 2776. We look forward to the opportunity to connect with you in sunny Orlando. ?? #AAD2025 #GlobalCRO #DermatologyCRO
-
-
?? Symbio is once again proud to be an exhibitor at the upcoming American Academy of Dermatology Annual Meeting (AAD2025), alongside our colleagues from Dow Development Laboratories, LLC (DDL). This year's meeting will be held at the Orange County Convention Center from March 7-11 in Orlando, Florida. Symbio looks forward to connecting and discussing the latest advancements in dermatology, with industry leaders and experts. We are excited to share with you how Symbio and Dow Development Laboratories, LLC (DDL) can strategically manage all aspects of your clinical trial. Visit us at booths 2774 & 2776 to meet our team. #AAD2025 #Dermatology #Clinicaltrials #GlobalCRO
-
-
Symbio colleagues Shanna Smith and Molly McMahon are proud to be attending this week's SCOPE, 16th Annual Summit in Orlando, FL. It's been an exciting week at this year's SCOPE, enjoying in-depth conversations and networking with industry professionals. Please feel free to reach out to Molly or Shanna, they would love to discuss how Symbio can help achieve your clinical research goals. #SCOPESummit #ClinicalTrials #GlobalCRO
-
-
?? Symbio colleagues are in Paris and excited for the start of IMCAS. Please stop by to visit us at booth K203. Looking forward to seeing you! #IMCAS2025 #GlobalCRO #MedicalAesthetics #RegenerativeMedicine
-
-
?? Symbio is excited to be attending the upcoming SCOPE 16th Annual Summit in Orlando, FL taking place February 3-6. During this 4-day comprehensive program, attendees from over 1,200 organizations and 30 different countries come together to discuss the latest innovations to improve clinical operations, trials and research. Our Symbio colleague Molly McMahon will be in attendance, looking forward to in-depth discussions and networking with industry professionals. Please feel free to contact Molly at [email protected], to discuss how Symbio can help achieve your clinical research goals. Excited to see you at SCOPE ! #SCOPESummit #ClinicalTrials #GlobalCRO
-
Only one week away! Symbio is excited to be an exhibitor at the upcoming IMCAS World Congress in Paris on January 30 - February 1, 2025. We look forward to meeting and connecting with professionals and experts from around the world to share the latest breakthroughs and innovations in Medical Aesthetics and Regenerative Medicine. Join our colleagues -- Dr. Peter Bernthaler, Dr. Dave Bruce, Chad Troller and Shanna Smith at Symbio booth K203. We look forward to providing insights into Symbio and discuss how we can meet and exceed your clinical research needs. Send us a note, we would love to connect! #IMCAS2025 #GlobalCRO #MedicalAesthetics #RegenerativeMedicine
-